Increased haemorrhage risk with idraparinux leads to trial termination
- 8 Downloads
KeywordsAtrial Fibrillation Warfarin Renal Impairment Acenocoumarol Antagonist Group
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.Amadeus Investigators.Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Lancet 371: 315-321, No. 9609, 26 Jan 2008Google Scholar
© Adis International limited or Adis Data Information BV 2008